Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DZD9008 is a rationally designed selective, irreversible EGFR/HER2 inhibitor.
Description | DZD9008 is a rationally designed selective, irreversible EGFR/HER2 inhibitor. |
Targets&IC50 | EGFR exon 20 ASV insertion:51.9 nM (IC50), Her2 exon 20 YVMA insertion:21.2 nM (IC50), EGFR L858R/T790M:1 nM (IC50), EGFR exon 20 NPH:51.2 nM (IC50) |
Synonyms | HER1, Her2, (S)Sunvozertinib, mutant forms of ErbB, Epidermal growth factor receptor, (S)-Sunvozertinib, lung, DZD9008, ErbB-1, inhibit, Btk, breast cancer, N-[5-[[4-[5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide, (S)-DZD9008, Inhibitor, EGFR, Bruton tyrosine kinase, (S) Sunvozertinib |
Molecular Weight | 584.09 |
Formula | C29H35ClFN7O3 |
CAS No. | 2370013-49-1 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 55 mg/ml (94.16 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.